Sandercock Brett 4
4 · RESMED INC · Filed Dec 2, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
Sandercock Brett
Chief Financial Officer
Transactions
- Sale
ResMed Common Stock
2025-12-01$244.16/sh−1,000$244,160→ 87,495 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.